Background
Malignant melanoma is the most aggressive form of skin cancer whose incidence still increases worldwide. Melanomas arise from the transformation of benign melanocytes or nevi which can develop into dysplastic lesions before progressing into primary melanomas that can further invade into the dermis and metastasize via hematogenous or lymphogenic routes to distant sites [
1]. Initiation and progression of melanoma have been associated with activation of key signaling pathways involved in proliferation, survival and dissemination. These include the Ras/Raf/MEK/ERK (MAPK) and PI3K/AKT signaling pathways as well as the Wnt/beta-catenin signaling pathway [
2].
Protein kinases play a central role in signal transduction. By reversible phosphorylation of its substrate proteins, they exert influence on their activity, localization and function and thus are involved in almost all cellular processes and functions. The casein kinases (CK) belong to the serine/threonine kinases that are involved in a variety of cellular processes. Isoforms of the casein kinase 1 (CK1) family have been shown to phosphorylate key regulatory molecules involved in cell cycle, transcription and translation, the structure of the cytoskeleton, cell-cell adhesion and in receptor-coupled signal transduction. CK1 isoforms are key regulators of several cellular growth and survival processes, including Wnt, Hedgehog and p53 signaling, cell cycle control, DNA repair and apoptosis [
3,
4].
In humans, six CK1 isoforms exist (α, γ1, γ2, γ3, δ and ε) and several splice variants for CK1α, δ, ε and γ3 have been identified. All CK1 isoforms possess a highly conserved kinase domain, but differ in length and sequence of the N-terminal and especially the C-terminal non-catalytic domains. CK1α plays a role in the mitotic spindle formation during cell division and in DNA repair mechanisms and further participates in RNA metabolism [
3,
4]. The CK1 isoforms δ and ε are known to be important regulators in the circadian rhythm of eukaryotic cells. CK1α regulates apoptotic signaling pathways, however, there seem to be cell type-specific differences. In addition to the involvement in apoptotic signaling pathways, the CK1 isoforms α, δ and ε have important regulatory functions in the Wnt/β-catenin signaling pathway and seems to act in a concerted manner [
5,
6]. Dishevelled (Dvl) is a key component in the Wnt/β-catenin signaling pathway. Upon pathway activation by Wnts, Dvl becomes phosphorylated by CK1 δ/ε [
7]. CK1α acts as a negative regulator of the the Wnt/β-catenin signaling pathway by acting as a priming kinase for β-catenin phosphorylation on Ser45 which is a pre-requisite for further phosphorylations by GSK3β at the Ser/Thr residues 33, 37 and 41 [
6,
8]. Without this priming phosphorylation β-catenin is not degraded and gets stabilized. A down-regulation of CK1α thus leads - due to the lack of “priming” phosphorylation - to an accumulation of cytoplasmic β-catenin. Indeed, we could show in metastatic melanoma cells that CK1α is downregulated which correlated with increased β-catenin stability [
9].
The tumor suppressor protein p53 as well as the p53 interacting proteins MDM2 and MDMX are substrates of the three CK1 isoforms CK1α, CK1δ and CK1ε. In different cell systems CK1α and CK1δ are described to regulate p53 activity by phosphorylation of p53 itself or the p53 interacting proteins MDM2 and MDMX [
3,
4,
10,
11]. Furthermore, the activity of p53 correlates with CK1α and CK1δ expression under stress conditions which points to an autoregulatory loop between CK1 isoforms and p53 [
10,
11].
Some evidence points to an altered expression or activity of different CK1 isoforms in tumor cells. Database analyses from tumor cell lines and tissues indicated that the CK1δ and CK1ε isoforms might be slightly overexpressed on RNA level in some tumor types including melanoma, whereas RNA expression of CK1α is more variable but low in melanoma [
4]. The CK1γ1-3 isoforms seem to be rather low in different cancers types. Expression analysis of CK1α in melanoma datasets clearly revealed a reduction in mRNA expression during melanoma progression and we could confirm the reduction of CK1α expression in metastatic melanoma cells on RNA and protein level [
4,
9]. However, expression of the other CK1 isoforms has not been systematically analyzed in melanoma cells until now. Furthermore, it is not known whether there is a functional redundancy of the CK1 isoforms in the regulation of cell survival and tumorigenesis since several substrates are shared within the CK1 family such as β-catenin in the canonical Wnt pathway and p53 or Mdm-2 in the p53 signaling pathway [
3,
4].
To identify the role of the different CK1 isoforms during melanoma progression we analyzed in this study a) the expression of the CK1 isoforms in melanoma cells of different progression stages in vitro and in vivo, b) the reciprocal influence of CK1 isoform expression for the α, δ and ε family members and c) the functional effects of gene expression modulation of individual CK1-isoforms (alpha, delta and epsilon) on melanoma cell survival, proliferation, migration and invasion.
Methods
Cell culture
Human melanoma cell lines were cultured for this study in RPMI 1640 medium with 2 mM L-Glutamine and 10 % fetal bovine serum (FBS; Biochrom, Berlin, Germany), penicillin, and streptomycin. They were subcultured 1–2 times a week when they reached 80 % confluency using Trypsin/EDTA (0.05 %/0.02 %) for detachment [
9,
12]. The melanoma cell lines Malme-3 M, MDAMB435, M14, UACC62, SKMel28 and A375 originated from the NCI60 cell panel of the National Cancer Institute (NCI-DCTD repository). The melanoma cell lines WM35, WM115, WM793, WM3734, WM266-4, WM1366, 1205 LU, and 451 LU were generously provided by M. Herlyn (Philadelphia, USA). SbCl2 and SKMel19 were provided by C. Garbe (Tübingen, Germany). SKMEL30 was obtained from the DSMZ (Braunschweig, Germany) and SKMel147 was a kind gift of M. Soengas (Madrid, Spain). Melanocytes, primary fibroblasts and keratinocytes were isolated from human foreskin as described previously [
13‐
15]. All of the cell lines used in our study were authenticated by sequence analysis of defined genes.
2.5 × 105 melanoma cells in 6well cavities were transfected with 50 pmol siRNA using RNAiMAX (Invitrogen, Darmstadt, Germany) according to the manufacturers protocol. The following siRNAs were used: siCSNK1A1 sense gaauuugcgauguacuuaa-dTdT, siCSNK1A1 antisense uuaaguacaucgcaaauuc-dTdG; siCSNK1D sense ugaucagucgcaucgaaua-dTdT, siCSNK1D antisense uauucgaugcgacugauca-dTdT; siCSNK1E sense ccuccgaauucucaacaua-dTdT, siCSNK1E antisense uauguugagaauucggagg-dGdA; siNONSIL sense acaacauucauauagcugccccc, siNONSIL antisense gggggcagcuauaugaauguugu (all synthesized by biomers.net, Ulm, Germany)
Overexpression of CK1α/ δ/ ε
Wild type CK1 isoform cDNA was amplified using the Human Multiple Tissue cDNA (MTC) Panel II (Clontech, Saint-Germain-en-Laye, France) and isoform specific primers. CK1 cDNAs were cloned into the inducible lentiviral vector PLVX-tight-PURO (Clontech) by using In-fusion-HD Liquid Kits (Clontech) according to the manufacturer’s protocol. Sanger-sequencing was performed for verification of the correct cloned cDNA. Lentiviral particles were produced in HEK293T cells using the second-generation packing and envelope plasmids pCMVΔR8.2 and pMD2.G. Cells were transduced with lentiviruses as described previously [
16] and doxycycline inducible melanoma cells were generated according to the manufacturer’s instructions (Tet-on Advanced System, Clontech). For overexpression of CK1α the previously described adenovirus was used [
9].
Inhibitor and doxycycline treatments
Small molecules were dissolved in DMSO and treatments were carried out using the indicated concentrations with vehicle controls. The following substances were used: Pyrvinium pamoate (Sigma, Taufkirchen, Germany), IC261 (Sigma), D4476 (Sigma), PF670462 (Sigma). Doxycycline hyclate (Applichem, Darmstadt, Germany) was dissolved in ddH2O and used at the indicated concentrations.
4-Methylumbelliferyl heptanoate (MUH) viability assay
For the analysis of proliferation and survival of melanoma cells, 2.5x103 cells were seeded into 96-well plates and cultured with the indicated inhibitors for the indicated periods of time. After washing of the cells with PBS, 100 μg/ml 4-methylumbelliferyl heptanoate (Sigma, Taufkirchen, Germany) in PBS were added and incubated for 1 h at 37 °C. Microplates were measured in a fluorescence microplate reader (Berthold, Bad Wildbad, Germany) with Ex355/Em460 nm in sixtuplicates. Dose–response curves were generated using GraphPad Prism version 6 (GraphPad Prism Software Inc.).
Cell cycle assay
2 x105 melanoma cells per 6-well cavity were seeded and either transfected using siRNA or treated with 4 μg/ ml doxycycline to induce the overexpression of CK1δ and ε or transduced with the adenovirus (CK1α overexpression). Cells were cultured for 48 h before permeabilization and fixation of the cells in 70 % ice-cold ethanol for at least 1 h. Then they were re-suspended in PBS with 100 μg/ml RNAseA (Applichem, Darmstadt, Germany) and 50 μg/ml propidium iodide (Sigma, Taufkirchen, Germany) and stained for 30 min. FACS analysis for the detection of the distribution of the cells in the each cell cycle phase was performed with a LSRII FACS (BD, Heidelberg, Germany) using the FACSDiva software.
3D Melanoma spheroid culture
2.5 × 103 SKMel19 cells were cultured on 1.5 % noble agar (Difco/BD, Heidelberg, Germany) coated 96well plates to form spheroids within 3 days. For overexpression of CK1 isoforms either 2 μg/ml doxycycline were added on the second day or the medium was supplemented with the adenovirus. After 3 days spheroids were embedded into 1 mg/ml collagen I (Corning/BD, Heidelberg, Germany) diluted in complete growth medium and cultured for four more days. In case of treatment inhibitors were added to the medium. Daily microphotographs were taken and the area of the spheroids was measured using ImageJ and normalized to the size at day 0 after collagen embedding for the evaluation of tumor cell invasion into the collagen matrix. After 4 days spheroids were stained using 1 μM calcein-AM (Life technologies, Darmstadt, Germany) and 100 ng/ml propidium iodide (Sigma, Taufkirchen, Germany) for fluorescence live-dead staining of the melanoma cells. Fluorescence was detected with an Axiovert fluorescence microscope (Zeiss, Jena, Germany). Mean fluorescence intensities of the red channel were used to determine relative cell death induction.
Quantitative PCR
Total RNA was extracted from cells using the NucleoSpin RNA kit (Machery-Nagel, Dueren, Germany). Complementary DNA was made out of 1 μg total RNA using SuperScript II reverse Transcriptase (Invitrogen, Darmstadt, Germany) according to the manufacturer’s protocol. Quantitative real-time PCR (qRT-PCR) was performed with the SYBR green mix LightCycler 480 (Roche, Mannheim Germany). The relative expression levels of CK1 isoforms were determined using the ∆∆Ct-method method with ACTINB or 18S rRNA as reference genes. The primer sequences were as follows: CSNK1A1 forward 5’-aatgttaaagcagaaagcagcac-3’ and reverse 5’-tcctcaattcatgcttagaaacc-3’. CSNK1D forward 5’-acaacgtcatggtgatggag-3’ and reverse 5’-gaatgtattcgatgcgactgat-3’. CSNK1E forward 5’-tgagtatgaggctgcacagg-3’ and reverse 5’-tcaaatggcacacttgtctgt-3’. CSNK1G1 forward 5’-ctgtgaccgaacatttactttga-3’ and reverse 5’-tgcacgtattccattcgaga-3’. CSNK1G2 forward 5’-gaccttcacgctcaagacg-3’ and reverse 5’-ccggtagattaggctcttggt-3’. CSNK1G3 forward 5’-tgcaacaatccaaaaaccagt-3’ and reverse 5’-ctgcaaggtgagctctcaaa-3’. ACTINB forward 5’-ttgttacaggaagtcccttgcc-3’ and reverse 5’-atgctatcacctcccctgtgtg-3’. 18S rRNA forward 5’-cggctaccacatccaaggaa-3’ and reverse 5’-gctggaattaccgcggct-3’.
Western blot
Protein lysates (30 μg) were subjected to SDS-PAGE and semi-dry blotting onto PVDF membranes (Roche, Mannheim, Germany). The antibodies used were as follows: anti-CK1α (Santa Cruz Biot., Heidelberg, Germany), anti-CK1δ (Santa Cruz Biot.), anti-CK1ε (Santa Cruz Biot), anti-p53 (Santa Cruz Biot), anti-p21 (Cell Signalling, Heidelberg, Germany), anti-β-catenin (Cell Signalling), anti p-S45-β-catenin (Cell Signalling) anti-β-actin (Cell Signalling). HRP conjugated secondary antibodies were used (Cell Signalling and Santa Cruz) and ECL substrates for chemoluminiscent detection. Densitometric semi-quantification was done by normalizing the band intensities of the target protein to the signal of β-actin with Scion Image.
Luciferase reporter assay
2.5 × 105 melanoma cells were seeded into 6well plates and transfected with 2 μg Super8xTOPFlash 16 h porst seeding using ScreenFectA (Genaxxon, Ulm, Germany) as recommended by the manufacturer. Twenty-four hours later cells were reseeded into 96 well cavities and the expression of isoforms was induced by the addition of doxycycline or of the adenovirus for 48 h. Then cells were lysed with 50 μl of passive lysis buffer (Promega, Mannheim, Germany) and luciferase activity was analyzed using D-luciferin as a substrate (Sigma) in a TriStar luminometer (Berthold, Bad Wildbad, Germany).
Immunofluorescence analysis of melanocytic biopsies
Nevi, primary and metastatic melanoma FFPE biopsies were sectioned, heat induced epitope retrieval (HIER) was performed using citrate buffer pH6 and the sections were stained using 1:100 rabbit anti-CK1α (Abcam ab 136052), 1:1000 mouse anti-CK1δ (Abcam ab85320) and 1:100 goat anti-CK1ε (Santa Cruz sc-6471). As secondary antibodies donkey anti-goat(Cy3), donkey anti-mouse(Cy2) and donkey anti-rabbit(Cy5) were used (all 1:250; JacksonImmunoResearch/Dianova, Hamburg, Germany) before staining the nuclei with 1 μg/ml DAPI (Sigma, Taufkirchen, Germany). Biopsies were microscopically analyzed using a confocal microscope system (Leica TCS SP2, Heidelberg, Germany) and the mean fluorescence intensity of representative cells was quantified using the Leica LCS software. For semi-quantification the mean fluorescent intensities of at least 30 cells per sample were background subtracted and presented as relative fluorescence units.
Kinase assay (K-LISA)
A 23mer peptide containing the exon 3 phosphorylation sites of β-catenin was synthesized as previously described [
9] and the NH
2 terminus was labeled with biotin. Melanoma cells were lysed using passive lysis buffer (Promega, Mannheim, Germany), and 5 μg of the protein lysates were incubated in kinase buffer (Cell Signalling, Heidelberg, Germany) together with 10 μg of biotin-labeled peptide for 30 min at 37 °C in streptavidin-coated 96well plates (Life technologies, Darmstadt, Germany). Plates were washed with PBS-T and anti–phospho-Ser45-β-catenin antibody (Cell Signaling) was added (1:500). HRP-conjugated secondary antibody (Cell Signalling) was used to detect the phosphorylated substrate measuring TMB substrate (Cell Signalling) at 450 nm in a microplate reader (Berthold, Bad Wildbad, Germany).
Migration and invasion assay
Skin reconstructs
Organotypic skin reconstructs were prepared as described previously [
13,
17,
18]. SbCl2 melanoma cells were transfected with the indicated siRNAs 24 h before epidermal reconstruction. Ten days after air-lifting the model reconstructs were fixed, paraffine embedded, sectioned, and H&E staining revealed the invasive capacity after knockdown of CK1α.
Boyden chamber experiments
Invasion was assayed using invasion chambers coated with or without Matrigel basement membrane matrix (BD Biocoat Matrigel invasion chambers, BD Biosciences, Heidelberg, Germany) as described previously [
9,
16]. After incubation for 20 h at 37 °C the invaded cells were fixed and counted after cell staining with hematoxilin-eosin. The assays were performed in triplicates, six fields were counted per transwell filter and the invasion index was calculated according to the manufacturerer’s protocol.
Real-time migration assay
The kinetics of cell migration was assayed using the xCELLigence Real-Time Cell Analyzer (RTCA DP; Roche). CIM-plate 16 wells used and 10,000cells were plated in each well using serum-free DMEM. The lower medium chamber contained DMEM with 10 % FCS. Cells were allowed to settle for 30 min at room temperature before being placed in the RTCA DP in a humidified incubator at 37 °C with 5 % CO2. Data were recorded every 15 min for 24 h. Plotted curves represent the averages from three independent measurements.
Discussion
Isoforms of the CK1 family have been shown to phosphorylate key regulatory molecules involved in cell cycle, transcription and translation, the structure of the cytoskeleton, cell-cell adhesion and in receptor-coupled signal transduction. Although they share highly conserved kinase domains, they differ significantly in the non-catalytic domains, suggesting that each isoform may play a specific role in regulating biological processes [
3,
4]. CK1 family members share a substrate sequence consensus in which position n-3 is necessarily occupied by an acidic group or a phosphor-amino acid. This consensus is D/E X X S/T for unprimed substrates or S/T-PO4 X X S/T for primed targets. However also non-consensus substrates exist like β-catenin and NFAT-4 hinting at putative CK1- isoform specific functions [
3,
4]. The expression as well as the functional relevance of each CK1- isoform in tumor cells and a possible functional redundancy have not been comparatively analyzes so far. We describe for the first time the expression of the dominantly expressed CK1- isoforms α, δ and ε in melanoma cells and their functional relevance in melanoma progression. We provide strong evidence for a non-redundant and dominant role of CK1α compared to the other CK1 isoforms in tumorigenesis supporting our previous hypotheses [
9]. We show that CK1α dominantly influences proliferation, invasion and progression of melanoma cells, whereas CK1δ and CK1ε do not significantly influence melanoma cell survival, proliferation, migration and invasion in vitro. This was unexpected since all three CK1- isoforms have been described to play key roles in cell proliferation and in the control of signaling pathways known to be important in tumor cells.
CK1α can be found at the centrosomes, microtubule asters and the kinetochore [
3,
4,
24] and plays a role in the mitotic spindle formation during cell division and in DNA repair mechanisms as well as in RNA metabolism [
25,
26]. CK1δ is also involved in regulating cell cycle progression. It interacts with the spindle apparatus and regulates phosphorylation of α-, β- and γ − tubulin [
27‐
29]. In addition, it was shown that checkpoint kinase 1 (Chk1) is able to interact and specifically phosphorylate CK1δ and by this regulate the kinase activity [
30]. Furthermore, inactivating mutations in CK1δ are able to impair SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo [
31] strengthening the important function of CK1δ in cell proliferation. CK1ε is able to interact with mitochondrial proteins in ovarian cancer cells and by this increase growth and survival of the tumor cells [
32]. Furthermore, in breast cancer cells CK1ε is a key regulator of cell proliferation by modulating protein synthesis. CK1ε is able to phosphorylate the translation factor 4E-BP1, thereby regulating cap-dependent translation [
33]. In addition, fibrosarcomas seem to depend on CK1ε and knocking down other isoforms of CK1 was not effective at inducing growth arrest in these cells [
34]. However, one study shows that re-expression of CK1α in a lung cancer cell line in which the expression of CK1α is also low causes reduced cell proliferation in vitro and tumor growth in vivo [
35]. Another study shows that a pharmacological increase of CK1α protein significantly diminished melanoma cell migration [
36]. Furthermore, it was shown that activation of CK1α by pyrvinium inhibits the proliferation of colon carcinoma cells through inhibition of the Wnt / beta-catenin signaling pathway [
22].
Despite the important role of these CK1 isoforms in cell cycle regulation and progression in different tumor types CK1δ and ε seems to be functionally redundant in melanoma cells since we find no functional effect on cell cycle or tumor progression after modulation of their expression level in melanoma cells. In contrast, overexpression of CK1α induces cell cycle arrest and apoptosis in metastatic melanoma cells and inhibits migration and invasion, whereas downregulation of CK1α in radial growth phase melanoma cells induces invasive tumor growth with a slightly reduced proliferation rate confirming our previous results [
9]. This implies that each CK1- isoform seems to have a unique function in promoting the integrity and proliferation of specific types of tumor cells.
In various cancer types CK1- isoforms are overexpressed. Especially the CK1δ and CK1ε isoforms are overexpressed in most tumor types compared to the respective benign tissues [
4]. However, we found that during melanoma progression protein expression of the CK1- isoforms α, δ and ε is downregulated. This was consistently seen for CK1α in vitro and in vivo, whereas expression of the CK1 δ and ε isoforms are more heterogeneous as the in vitro and in vivo expression data are not consistent.
It was reported that CK1ε enhances the β-catenin-dependent proliferation in breast cancer [
37] and a point mutation in CK1δ promotes the emergence of colorectal adenomas [
38]. In contrast, a down-regulation of CK1δ and ε-isoforms in a variety of tumor cell lines of different origin induced cell cycle arrest and apoptosis. These effects are also Wnt/β-catenin-independent, but dependent of activated RAS and inactive p53 [
4,
39,
40]. Furthermore, it was shown that impaired CK1δ activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo [
31]. We clearly show now in this study that in the different melanoma cell models these CK1- isoforms have no role in cell cycle progression and migratory and invasive melanoma growth. However, overexpression of CK1δ or CK1ε resulted in higher activity of the Wnt/β-catenin signaling pathway and an increased p53 activity, whereas CK1α overexpression inhibited Wnt/β-catenin signaling and p53 activity. However, the suppressive effect on p53 activity seems to depend on a gene dosage effect of CK1α. Furthermore we showed that in metastatic melanoma cells CK1α is downregulated resulting in higher transcriptional activity of the Wnt/beta-catenin signaling pathway confirming our previous study pointing out that CK1α is a tumor suppressor in melanoma cells [
9]. It seems that depending on the molecular background and oncogene addictions in the tumor cells different CK1 isoforms have dominant roles in the respective tumor types.
It is known that the CK1- isoforms CK1α, CK1δ and CK1ε are capable to N-terminally phosphorylate the tumor suppressor protein p53 in vitro and in vivo. This leads to a reduced interaction of p53 with MDM2 and thus to a stabilization and activation of p53 [
3,
4]. However, phosphorylation of MDM2 by CK1α, CK1δ and CK1ε can also promote p53 binding and degradation. Furthermore, CK1δ is known to phosphorylate MDM2 on other sites, which prevents the degradation of p53 [
41]. In addition it could be shown that after genotoxic stress it comes to a transcriptional activation of CK1δ by p53 pointing out to an autoregulatory loop between these two proteins [
3,
4]. Therefore, the outcome of CK1-kinase activation on p53 signaling has to be carefully analyzed in each tumor model.
The p53 signaling pathway seems to play a pivotal role in regulating CK1α activity. Our first description of invasive tumor growth due to knockdown of CK1α was substantiated by an ensuing work, which demonstrated the rapid invasive growth of transformed cells in the small intestine of mice when p53 is inactivated together with CK1α [
42]. This suggests that loss of p53 in combination with loss of CK1α activity favors invasive tumor growth. Interestingly, p53 is a substrate of CK1α. Knockdown of CK1α induces p53 transcriptional activity by reducing the inhibitory effect of the MDM2 homologue MDMX for p53 [
43]. It was further shown that CK1α plays a central role in mediating MDM2 control of p53 [
11]. CK1α stimulates p53 under stress conditions probably by direct phosphorylation of p53 [
10,
40]. Thereby, CK1α could be a cellular fine-tuning tool for the regulation of p53 activity, which is dependent on the gene dosage.
Abbreviations
Chk1, checkpoint kinase 1; CK, casein kinase; Dvl, dishevelled; FBS, fetal bovine serum; HE, hematoxilin-eosin; MM, metastatic melanoma; MUH, methylumbelliferyl heptanoate; NHM, normal human melanocytes; PI, propidium iodide; RGP, radial growth pase; RTCA, real-time cell analyzer; VGP, vertical growth phase